
IBM · NYSE
The supplied consensus is Hold across 14 analysts, with a mean price target of $269.50; low and high targets are unavailable, so the target spread and a meaningful cluster cannot be established. Truist’s cited target is $260, below that mean, but the evidence does not identify the most- or least-bullish named analyst. No dated analyst actions establish the direction of revisions specifically over the past week. The available signals are mixed: Truist raised its target from $240 to $260 after an earnings beat, while Simply Wall St says its aggregate fair-value estimate fell from $195 to $174 on more cautious revenue and margin assumptions and a lower future multiple. The disagreement is therefore about growth and valuation, not just near-term earnings.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Wall Street Zen | — | — | — | Sep 12, 2026 | Open the report this row came from | |
| Weiss Ratings | — | — | — | Jun 24, 2026 | Open the report this row came from |